The Killer Saccharomyces cerevisiae Toxin: From Origin to Biomedical Research

Carlos Molina-Vera1, Verónica Morales-Tlalpan1,2, Amairani Chavez-Vega1

  • 1Membrane Biophysics and Nanotechnology Laboratory, Natural Sciences Faculty, Autonomous University of Quéretaro, Av. De las Ciencias S/N, Juriquilla, Querétaro 76220, Mexico.

Microorganisms
|January 8, 2025
PubMed

Insights

The killer yeast system in Saccharomyces cerevisiae involves M viruses and helper viruses. Killer toxins, like K1 and K2, show potential as antimicrobial agents and in biological control.

Area of Science:

  • Microbiology
  • Virology
  • Biochemistry

Background:

  • The killer system of Saccharomyces cerevisiae is characterized by the co-infection of M viruses and helper viruses.
  • Different M virus types (ScV-M1, ScV-M2, ScV-M28, ScV-Mlus) encode distinct killer toxins (K1, K2, K28, Klus).

Purpose of the Study:

  • To review the key aspects of Saccharomyces cerevisiae killer toxins.
  • To explore their origin, evolutionary implications, and potential applications.
  • To detail the mechanisms of action of various killer toxins.

Main Methods:

  • Literature review focusing on viral agents, toxin types, and mechanisms of action.
  • Analysis of research on antimicrobial and biological control applications.
  • Synthesis of information on evolutionary aspects of killer systems.

Main Results:

  • S. cerevisiae killer toxins exhibit diverse mechanisms of action against susceptible cells.
  • These toxins have potential applications in the biomedical field as antimicrobial agents.
  • The killer system offers a strategy for biological control.

Conclusions:

  • Understanding killer toxin mechanisms is crucial for harnessing their therapeutic and control potential.
  • The evolutionary dynamics of killer viruses provide insights into microbial interactions.
  • Further research can optimize the use of killer toxins in various applications.